FDA Press Releases
FDA Press Releases
The feed below is an automatic RSS feed from the FDA website.
- FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children
- FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients
- FDA Announces Real-Time Release of Complete Response Letters, Posts Previously Unpublished Batch of 89
- FDA Advances Rare Disease Drug Development with New Evidence Principles
- FDA Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging Following Increasing Reports of Accidental Exposure
- FDA Begins Real-Time Reporting of Adverse Event Data
- HHS Allows FDA Emergency Use of Animal Drugs to Combat New World Screwworm, Protect U.S. Food Supply
- FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis
- Statement from FDA Commissioner Marty Makary, M.D., M.P.H., on Florida Restriction of 7-OH Opioid Products
- FDA Commissioner Makary, USDA Secretary Rollins Celebrate Proposed Modernization of Orange Juice Regulations to Benefit American Growers
- A Statement from FDA Commissioner Marty Makary, M.D., M.P.H: Announcing Resolution of the IV Saline Solutions Shortage
- FDA Announces New FDA PreCheck Program to Boost U.S. Drug Manufacturing
- FDA Names Top HHS Lawyer as Chief Counsel
- FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
- FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers